Variant report
Variant | esv3356838 |
---|---|
Chromosome Location | chr3:162407608-162409606 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs79362166 | chr3:162407608-162407609 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs550549919 | chr3:162407614-162407615 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs570465323 | chr3:162407620-162407621 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs572279195 | chr3:162407631-162407632 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs539558396 | chr3:162407635-162407636 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs111959485 | chr3:162407660-162407661 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs545781836 | chr3:162407669-162407670 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs147752974 | chr3:162407689-162407690 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs200837391 | chr3:162407698-162407699 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs573410033 | chr3:162407747-162407748 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs563964718 | chr3:162407754-162407755 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs575996699 | chr3:162407797-162407798 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs535634364 | chr3:162407801-162407802 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs555655831 | chr3:162407853-162407854 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs141957970 | chr3:162407882-162407883 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs544203035 | chr3:162407921-162407922 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs564098289 | chr3:162407966-162407967 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs188853376 | chr3:162408014-162408015 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs577956405 | chr3:162408054-162408055 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs202103409 | chr3:162408059-162408060 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs74829010 | chr3:162408069-162408070 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs7634217 | chr3:162408075-162408076 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs560368678 | chr3:162408169-162408170 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs528304575 | chr3:162408194-162408195 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs145811525 | chr3:162408195-162408196 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs138422391 | chr3:162408222-162408223 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs371552803 | chr3:162408233-162408234 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs7646046 | chr3:162408252-162408253 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
29 | rs7646137 | chr3:162408311-162408312 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs199669459 | chr3:162408313-162408314 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs200726596 | chr3:162408317-162408318 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs201912938 | chr3:162408318-162408319 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs373307783 | chr3:162408324-162408325 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs367969465 | chr3:162408371-162408372 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs550886617 | chr3:162408434-162408435 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs570472765 | chr3:162408435-162408436 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs539038983 | chr3:162408487-162408488 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs192673835 | chr3:162408594-162408595 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs375002272 | chr3:162408611-162408612 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs199907929 | chr3:162408612-162408613 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs546706767 | chr3:162408615-162408616 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs371910556 | chr3:162408616-162408617 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs566411060 | chr3:162408690-162408691 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs535674556 | chr3:162408694-162408695 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs555491929 | chr3:162408722-162408723 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs543039901 | chr3:162408725-162408726 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs560390048 | chr3:162408745-162408746 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs117645616 | chr3:162408756-162408757 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs73010366 | chr3:162408763-162408764 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs182741345 | chr3:162408768-162408769 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Retinoblastoma | 21504564 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Lung cancer | 18438408 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Melanoma | 18172304 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Breast cancer | 22032731 | CNVD |
Breast cancer | 16461572 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Cervical Cancer | 21857958 | CNVD |
Melanoma | 21693616 | CNVD |
Lung cancer | 21426551 | CNVD |
Cancer | 21637783 | CNVD |
Cervical cancer | 21063398 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oral cancer | 21386901 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 22065749 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Breast cancer | 16608533 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Non-small cell lung cancer | 19010865 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Ovarian clear cell carcinoma | 21343371 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16547154 | CNVD |
Breast cancer | 21364760 | CNVD |
Gastrointestinal stromal cancer | 20818650 | CNVD |
Prostate cancer | 16573809 | CNVD |
Breast cancer | 21785460 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
Malformation | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Breast cancer | 17133270 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Attention deficit hyperactivity disorder | 21324949 | CNVD |
Barrett''s adenocarcinoma | 18663352 | CNVD |
epilepsy | 18472482 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Myxofibrosarcoma | 16751306 | CNVD |
Parkinson disease | 21907011 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:162407400-162408800 | Enhancers | Dnd41 | blood |
2 | chr3:162408800-162413800 | Weak transcription | Dnd41 | blood |